To catalogue
Frau Pharma Carfilzomib
Frau Pharma Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often in combination with other medicines with a similar therapeutic effect.
Properties
- Pharma and Nutraceuticals Functions
- Supplement
Product families
Applications
Food & Nutrition — Nutrition & Well Being
- Nutraceuticals & Supplements
Product Families
Pharmaceuticals & Nutraceuticals — Nutraceuticals & Supplements
- Supplements & Functional Ingredients
Food Ingredients — Nutrition & Fortification
- Functional Ingredients
Other characteristics
- Benefit Claims (Health)
- Anti-Cancer Properties, Stimulates Immune System
- Anti-Cancer Properties
- Stimulates Immune System
- Usage
It is used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous treatments.
- Markets
- Food & Nutrition
- Technology
- Food Ingredients
- Pharmaceuticals & Nutraceuticals
- Food Ingredients Functions
- Supplement
